Fully updated and expanded, and now in full color with intuitive icons throughout, larger format, packed with its unique comparison charts, and with patient / caregiver handouts as printable PDFs - the widely acclaimed reference to psychotropic medications in children and adolescents is now more "user-friendly" than ever! This unique book fills the need for a comprehensive, yet compact and easy-to-use reference for all mental health professionals dealing with children and adolescents. Packed with the practical comparison charts for which it is renowned, other outstanding features of the Clinical Handbook of Psychotropic Drugs for Children and Adolescents are: * Independent, unbiased * Unique comparison charts (dosages, side effects, pharmacokinetics, interactions...) that allow you to see at a glance which medication is the most suitable for each patient * Instantly recognizable icons and full color throughout * Compiles the latest information from the published literature (scientific data, controlled clinical trials, case reports) and clinical experience in one easy-to-use reference * Includes monograph statements on use in children and adolescents and approved indications, as well as available data concerning off-label indications, findings from open and double-blind studies concerning doses, adverse effects, and other considerations * Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Health Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions, nursing implications; drug interactions; patient and caregiver instructions... All you need to know for each class of drug!!

The 'Clinical Handbook of Psychotropic Drugs', now in its 19th edition, has become a standard reference for psychiatrists, psychologists, physicians, nurses, and indeed virtually all categories of mental health professionals. It is easy to use with succinct bulleted information on all classes of medication.

Fully updated and expanded, in full color with intuitive icons throughout, packed with new and expanded comparison charts. The Clinical Handbook of Psychotropic Drugs has become a standard reference and practical tool for psychiatrists, psychiatric nurses, pharmacists, psychologists, physicians, and all mental health professionals. The new and fully updated 20th edition retains all the practical features for which the Clinical Handbook is renowned: Independent, unbiased; Packed with unique comparison charts (dosages, side effects, pharmacokinetics, interactions ...) that allow you to see at a glance which medication is the most suitable for each patient; Instantly recognizable icons and full color throughout, allowing you to find at a glance all the information you seek; The latest information on newly released drugs, adverse effects, approved indications; Succinct, bulleted information on all classes of medication: classification, available products (including US and Canadian trade names), on- and off-label indications (US FDA and Canada); pharmacology, dosing, pharmacokinetics; adverse effects, precautions, contraindications, toxicity; lab tests, precautions in young, old, and pregnant patients, nursing implications; drug interactions; patient instructions ... all you need to know for each class of drug! The latest information on Herbal and "Natural" Products, Unapproved Treatments, ECT, BLT, rTMS. - Publisher.

Quick and comprehensive information on psychotropic drugs for children and adolescents. Accurate and up-to-date Specific to children and adolescents Charts and tables help decision-making Icons and full color More about this book The Clinical Handbook of Psychotropic Drugs for Children and Adolescents is a unique resource to help you make the right choices about psychotropic medications for younger patients. The fifth edition of this widely acclaimed reference has been fully updated and expanded. Updated information on psychiatric disorders in children and adolescents Unique comparison charts (dosages, side effects, pharmacokinetics, interactions...) that allow you to see at a glance which medication is the most suitable for each patient Instantly recognizable icons in full color throughout, allowing you to quickly find all the information you seek: – General information on medications, availability, and indications – Drug action, dosing, pharmacokinetics, and related areas – Warnings and precautions – Patient-related information, such as lab monitoring recommendations, nursing implications, and patient advice Clearly written patient and caregiver information sheets as printable pdf files This book is a must for all mental health professionals working with children and adolescents who need an up-to-date, easy-to use, comprehensive summary of all the most relevant information about psychotropic drugs. New in this edition: New chapters on Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information for Common Psychotropic Drugs, and Aggression Management in Children and Adolescents Neuroscience-based nomenclature added to Product Availability tables Antipsychotic-Induced Extrapyramidal Side Effect (EPSE) chapter completely revised, plus new section on monitoring scales for EPSE Anxiolytics section on buspirone and benzodiazepine comparison table revised

Quick and comprehensive information on psychotropic drugs for adults. Accurate and up-to-date Comparison charts help decision-making Icons with full color Available both in print and online Downloadable patient information sheets More about this book The Clinical Handbook of Psychotropic Drugs has become a standard reference and working tool for psychiatrists, psychologists, physicians, pharmacists, nurses, and other mental health professionals. Independent, unbiased, up-to-date Packed with unique, easy-to-read comparison charts and tables (dosages, side effects, pharmacokinetics, interactions...) for a quick overview of treatment options Succinct, bulleted information on all classes of medication: on- and off-label indications, (US FDA, Health Canada), recommended dosages, US and Canadian trade names, side effects, interactions, pharmacodynamics, precautions in the young, the elderly, and pregnancy, nursing implications, and much more – all you need to know for each class of drug Potential interactions and side effects summarized in comparison charts With instantly recognizable icons and in full color throughout, allowing you to find at a glance all the information you seek Clearly written patient information sheets available for download as printable PDF files This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs. New in this edition Antidepressants chapter includes a new section on the NMDA receptor antagonist/CYP2D6 inhibitor combination product (dextromethorphan/bupropion) Antipsychotics updates include revised clozapine monitoring tables which now also contain monitoring requirements for patients with or without non-benign ethnic neutropenia Mood Stabilisers sections on Lithium and Anticonvulsants extensively revised Dementia chapter includes a new section on lecanemab, a new fast-track FDA-approved treatment for Alzheimer's disease Treatment of Substance Use Disorders includes revisions to buprenorphine dosing section that include a rapid micro-induction method (Bernese method) that allows treatment to start without waiting for patient to be in withdrawal Unapproved treatments of Psychiatric Disorders, Natural Health Products, and Pharmacogenetics chapters all substantially revised New formulations and trade names include: Auvelity (dextromethorphan/bupropion extended-release tablets), Invega Hafyera (paliperidone 6-monthly IM injection), Leqembi (lecanemab infusion), Subutex (buprenorphine sublingual tablets), Quviviq (daridorexant tablets)

The Clinical Handbook of Psychotropic Drugs, now in its 18th edition, has become a standard reference for thousands of psychiatrists, psychologists, physicians, nurses, pharmacists, and indeed virtually all categories of mental health professionals. This book is a must for everyone who needs an up-to-date, easy-to-use, comprehensive summary of all the most relevant information about psychotropic drugs. It features easy-to-read comparison charts with details of treatment options including available dosing forms and strengths. It offers clear advice regarding medication options and precautions. Potential interactions and side effects are summarized in comparison charts. Special precautions to consider when treating children and adolescents, pregnant patients, or the elderly are presented. It contains clearly written patient information sheets. Already widely regarded as the best practical guide on the market, the Clinical Handbook of Psychotropic Drugs now comes with an improved layout using color coding and readily recognizable icons for even more intuitive and user-friendly navigation.

The 16th edition of a comprehensive summary of relevant information about psychotropic drugs. Chapters on Bright Light Therapy (BLT) and Repetitive Transcranial Magnetic Stimulation (RTMS) are included.

This book offers a comprehensive survey of the current state of knowledge in the field of neuro-psychopharmacology in childhood and adolescence. In the first part, the essentials of neuro-psychopharmacology are presented in order to provide a deeper understanding of the principles and particularities in the pharmacotherapy of children and adolescents. This part includes information on neurotransmitters and signal transduction pathways, molecular brain structures as targets for psychiatric drugs, characteristics of psychopharmacological therapy in children and adolescents, ontogenetic influences on pharmacokinetics and pharmacodynamics, and pharmacotherapy in the outpatient setting. The part on classes of psychiatric medications, which covers antidepressants, antipsychotics, anxiolytics and sedative-hypnotics, mood stabilizers, and psychostimulants and other drugs used in the treatment of attention-deficit/hyperactivity disorder, provides sufficient background material to better understand how psychoactive drugs work, and why, when, and for whom they should be used. For each drug within a class, information on its mechanisms of action, clinical pharmacology, indications, dosages, and cognate issues are reviewed. In the third part, the disorder-specific and symptom-oriented medication is described and discerningly evaluated from a practical point of view, providing physicians with precise instructions on how to proceed. Psychiatric Drugs in Children and Adolescents includes numerous tables, figures and illustrations and offers a valuable reference work for child and adolescent psychiatrists and psychotherapists, pediatricians, general practitioners, psychologists, and nursing staff, as well as teachers.

This volume assists practicing mental health professionals in expanding their knowledge about nutritional and herbal interventions that can be attempted as alternatives to prescription medications. Designed to provide guidance for non-medical caregivers treating children and adolescents who present with emotional and/or behavioral difficulties such as such as depression, anxiety, ADHD, sleep difficulties, impulsivity, distractibility, and other psychological and psychiatric disorders, the volume provides a comprehensive discussion of naturopathic solutions based on existing research. In areas where research is not extensive, conclusions are provided about potentially beneficial effects based on the specific pharmacologic action of the compounds. Dosage for specific age groups, schedules of administration, dietary considerations (i.e., whether or not to take the supplement with food), monitoring for response and adverse effects, signs of dangerous reactions, and the need to control interactions with other compounds (i.e., prescription medications) are thoroughly reviewed with regard to each supplement discussed in the book. - Reviews specific psychological disorders (i.e. ADHD, depression, mania, anxiety, sleep difficulties, tic behaviors and autism) and the available data about their treatment with the use of nutritional and herbal supplements - Provides rationale for the use of every specific compound with detailed recommendations tailored for each age group with regard to the dosage, frequency of administration, possible dangers and monitoring for side effects - Discusses claims of efficacy used to market various products and ground those claims within fully vetted scientific research - Discusses neurobiology, pharmacodynamics and pharmokinetics in detailed but accessible language *Non-medical clinicians with limited knowledge of medicine and pharmacology come away with understanding of key issues involved in - Fully covers assessment, diagnosis & treatment of children and adolescents, focusing on evidence-based practices *Consolidates broadly distributed literature into single source and specifically relates evidence-based tools to practical treatment, saving clinicians time in obtaining and translating information and improving the level of care they can provide - Detailed how-to explanation of practical evidence-based treatment techniques *Gives reader firm grasp of how to more effectively treat patients - Material related to diversity (including race, ethnicity, gender and social class) integrated into each chapter *Prepares readers for treating the wide range of youth they will encounter in practice

This book is a practical and authoritative guide to diagnosis and treatment of child and adolescent depression in various clinical settings, health care systems, and cultures. Emphasis is placed on evidence-based precepts for treatment. The contributors address current controversies surrounding the potential risks of medications in children and discuss other biological treatments and psychotherapies. Key take-home points are listed at the end of each chapter. Flow charts and tables summarize treatment recommendations, and tables summarize evidence of effectiveness and quality of evidence. Also included are lists of other resources for clinicians, patients, and families.